NASDAQ:KIDS - Orthopediatrics Stock Price, News, & Analysis Sign in or create an account to add this stock to your watchlist. Get Started $26.10 -0.45 (-1.69 %) (As of 11/14/2018 01:07 PM ET)Previous Close$26.55Today's Range$26.02 - $26.6552-Week Range$14.00 - $39.81Volume735 shsAverage Volume39,553 shsMarket Capitalization$340.14 millionP/E Ratio-4.60Dividend YieldN/ABetaN/A ProfileDiscussionAnalyst RatingsChartEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesSEC FilingsSocial Media Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email OrthoPediatrics Corp., a medical device company, designs, develops, and markets anatomically appropriate implants and devices for the treatment of children with orthopedic conditions in the United States and internationally. The company's products comprise PediLoc, PediPlates, cannulated screws, PediFlex nail, PediNail products, PediLoc tibia products, locking cannulated blades, locking proximal femurs, spica tables, response spine systems, and pediguards; bandloc, a sub-laminar banding system; and sports medicine and other products, such as anterior cruciate ligament and medial patellofemoral ligament systems. Its products are used in the pediatric trauma and deformity procedures, as well as scoliosis procedures for the treatment of spinal deformity. The company serves pediatric orthopedic market, as well as caregivers. OrthoPediatrics Corp. was founded in 2007 and is headquartered in Warsaw, Indiana. Receive KIDS News and Ratings via Email Sign-up to receive the latest news and ratings for KIDS and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical Current SymbolNASDAQ:KIDS Previous Symbol CUSIPN/A Webwww.orthopediatrics.com Phone574-268-6379 Debt Debt-to-Equity Ratio0.62 Current Ratio5.67 Quick Ratio3.23 Price-To-Earnings Trailing P/E Ratio-4.60 Forward P/E Ratio-27.47 P/E GrowthN/A Sales & Book Value Annual Sales$45.62 million Price / Sales7.33 Cash FlowN/A Price / CashN/A Book Value$3.18 per share Price / Book8.21 Profitability EPS (Most Recent Fiscal Year)($5.70) Net Income$-8,930,000.00 Net Margins-55.97% Return on Equity-65.26% Return on Assets-35.95% Miscellaneous Employees69 Outstanding Shares12,810,000Market Cap$340.14 million OptionableNot Optionable Orthopediatrics (NASDAQ:KIDS) Frequently Asked Questions What is Orthopediatrics' stock symbol? Orthopediatrics trades on the NASDAQ under the ticker symbol "KIDS." How were Orthopediatrics' earnings last quarter? Orthopediatrics Corp (NASDAQ:KIDS) released its earnings results on Wednesday, October, 31st. The company reported ($0.15) EPS for the quarter, missing the Thomson Reuters' consensus estimate of ($0.12) by $0.03. The firm earned $15.82 million during the quarter, compared to analyst estimates of $15.19 million. Orthopediatrics had a negative net margin of 55.97% and a negative return on equity of 65.26%. The firm's quarterly revenue was up 27.8% on a year-over-year basis. During the same period last year, the business posted ($1.70) earnings per share. View Orthopediatrics' Earnings History. When is Orthopediatrics' next earnings date? Orthopediatrics is scheduled to release their next quarterly earnings announcement on Wednesday, March 6th 2019. View Earnings Estimates for Orthopediatrics. What guidance has Orthopediatrics issued on next quarter's earnings? Orthopediatrics issued an update on its FY 2018 earnings guidance on Wednesday, October, 31st. The company provided EPS guidance of for the period. The company issued revenue guidance of $57.025-57.253 million, compared to the consensus revenue estimate of $56.51 million. What price target have analysts set for KIDS? 3 brokers have issued 12 month price objectives for Orthopediatrics' shares. Their predictions range from $24.00 to $30.00. On average, they anticipate Orthopediatrics' stock price to reach $27.00 in the next year. This suggests a possible upside of 3.8% from the stock's current price. View Analyst Price Targets for Orthopediatrics. What is the consensus analysts' recommendation for Orthopediatrics? 3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Orthopediatrics in the last year. There are currently 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Orthopediatrics. Has Orthopediatrics been receiving favorable news coverage? Media coverage about KIDS stock has trended somewhat positive recently, according to InfoTrie Sentiment Analysis. The research group rates the sentiment of press coverage by reviewing more than six thousand blog and news sources in real time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Orthopediatrics earned a coverage optimism score of 1.7 on InfoTrie's scale. They also gave news coverage about the company a news buzz of 5.0 out of 10, indicating that recent press coverage is somewhat likely to have an effect on the company's share price in the near term. Who are some of Orthopediatrics' key competitors? Some companies that are related to Orthopediatrics include Atrion (ATRI), Nevro (NVRO), K2M Group (KTWO), AtriCure (ATRC), Luminex (LMNX), Orthofix Medical (OFIX), Tactile Systems Technology (TCMD), Cryolife (CRY), Cardiovascular Systems (CSII), Intersect ENT (XENT), OraSure Technologies (OSUR), SurModics (SRDX), AngioDynamics (ANGO), Cerus (CERS) and Antares Pharma (ATRS). Who are Orthopediatrics' key executives? Orthopediatrics' management team includes the folowing people: Mr. Mark C. Throdahl, Pres, CEO & Director (Age 67)Mr. Fred L. Hite, CFO & Director (Age 50)Mr. Daniel J. Gerritzen, VP of Legal & HR, Gen. Counsel and Sec. (Age 48)Mr. David R. Bailey, Exec. VP (Age 39)Mr. Gregory A. Odle, Exec. VP of Commercialization (Age 48) When did Orthopediatrics IPO? (KIDS) raised $52 million in an IPO on Thursday, October 12th 2017. The company issued 4,000,000 shares at $12.00-$14.00 per share. Piper and Jaffray Stifel served as the underwriters for the IPO and William Blair and BTIG were co-managers. Who are Orthopediatrics' major shareholders? Orthopediatrics' stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include BlackRock Inc. (3.17%), FMR LLC (2.98%), Wasatch Advisors Inc. (2.95%), Royce & Associates LP (1.41%), Allianz Asset Management GmbH (1.02%) and JPMorgan Chase & Co. (0.55%). Company insiders that own Orthopediatrics stock include Daniel J Gerritzen, David R Bailey, David R Pelizzon, Fred Hite, Harold Ruf and Kevin Unger. View Institutional Ownership Trends for Orthopediatrics. Which institutional investors are selling Orthopediatrics stock? KIDS stock was sold by a variety of institutional investors in the last quarter, including Wasatch Advisors Inc., Kornitzer Capital Management Inc. KS, FMR LLC, Brasada Capital Management LP and Royce & Associates LP. Company insiders that have sold Orthopediatrics company stock in the last year include Daniel J Gerritzen, David R Bailey, Fred Hite and Kevin Unger. View Insider Buying and Selling for Orthopediatrics. Which institutional investors are buying Orthopediatrics stock? KIDS stock was acquired by a variety of institutional investors in the last quarter, including Allianz Asset Management GmbH, BlackRock Inc., EAM Global Investors LLC, EAM Investors LLC, PNC Financial Services Group Inc., JPMorgan Chase & Co., JPMorgan Chase & Co. and Blair William & Co. IL. Company insiders that have bought Orthopediatrics stock in the last two years include David R Pelizzon and Harold Ruf. View Insider Buying and Selling for Orthopediatrics. How do I buy shares of Orthopediatrics? Shares of KIDS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Orthopediatrics' stock price today? One share of KIDS stock can currently be purchased for approximately $26.02. How big of a company is Orthopediatrics? Orthopediatrics has a market capitalization of $340.14 million and generates $45.62 million in revenue each year. The company earns $-8,930,000.00 in net income (profit) each year or ($5.70) on an earnings per share basis. Orthopediatrics employs 69 workers across the globe. What is Orthopediatrics' official website? The official website for Orthopediatrics is http://www.orthopediatrics.com. How can I contact Orthopediatrics? Orthopediatrics' mailing address is 2850 Frontier Drive, Warsaw IN, 46582. The company can be reached via phone at 574-268-6379 or via email at [email protected] MarketBeat Community Rating for Orthopediatrics (NASDAQ KIDS)Community Ranking: 2.6 out of 5 ( )Outperform Votes: 150 (Vote Outperform)Underperform Votes: 142 (Vote Underperform)Total Votes: 292MarketBeat's community ratings are surveys of what our community members think about Orthopediatrics and other stocks. Vote "Outperform" if you believe KIDS will outperform the S&P 500 over the long term. Vote "Underperform" if you believe KIDS will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 11/14/2018 by MarketBeat.com StaffFeatured Article: Do stock splits help investors?